Evidence map›Paper›PMID 40343352›Full record

ArticleNMC case report journal2025

Favorable Response to Conventional Chemoradiotherapy in Radiation-induced Glioma Harboring Coamplification of PDGFRA, KIT, and KDR: A Case Report and Literature Review.

Daisuke Tanikawa, Mitsuaki Shirahata, Kokyo Sakurada, Masayoshi Fukuoka, Reina Mizuno, Ayaka Sakakibara, Masayo Kaneko-Mishima, Takuro Ehara, Tatsuya Ozawa, Tomonari Suzuki and 3 more

Abstract readCase Reports
In one paragraph

Article in NMC case report journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Daisuke TanikawaDepartment of Neurosurgery/Neuro-oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
Mitsuaki ShirahataDepartment of Neurosurgery/Neuro-oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
Kokyo SakuradaDepartment of Neurosurgery/Neuro-oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
Masayoshi FukuokaDepartment of Neurosurgery/Neuro-oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
Reina MizunoDepartment of Neurosurgery/Neuro-oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
Ayaka SakakibaraDepartment of Breast Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
Masayo Kaneko-MishimaDepartment of Neurosurgery/Neuro-oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
Takuro EharaDepartment of Neurosurgery/Neuro-oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
Tatsuya OzawaDepartment of Neurosurgery/Neuro-oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
Tomonari SuzukiDepartment of Neurosurgery/Neuro-oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
Taku HommaDepartment of Diagnostic Pathology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
Shingo KatoDepartment of Radiation Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
Kazuhiko MishimaDepartment of Neurosurgery/Neuro-oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the most serious complications of cranial radiotherapy is the development of radiation-induced glioma, which is estimated to occur in 1%-4% of patients who have received cranial irradiation and has a worse prognosis than sporadic glioblastoma. Although comprehensive genetic analysis has recently uncovered the molecular characteristics of radiation-induced glioma, the full picture remains unclear due to its rarity. A 45-year-old man presented with generalized seizures caused by multiple brain tumors involving the right frontal lobe, thalamus, and brainstem. The patient had a history of whole-brain radiotherapy for recurrent Burkitt's lymphoma at the age of 12. He underwent craniotomy, and the histological diagnosis revealed a high-grade glioma with isocitrate dehydrogenase-wildtype, which was presumed to be a radiation-induced glioma that developed 33 years after whole-brain irradiation. Next-generation sequencing identified a

Indexed as

4q12 amplificationnext-generation sequencingradiation-induced gliomaradiotherapy

Identifiers

PMID40343352
PMCPMC12059294

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.